The CGTLive™ Dermatology specialty topic page contains clinical news coverage of the latest updates on cell therapies, gene therapies, and engineered and regenerative medicines developed for dermatological skin conditions. It also houses video interviews with key opinion leaders in the field of dermatology to keep you up to date about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings.
September 6th 2024
Review top news and interview highlights from the week ending September 6, 2024.
The Lupus Approach: CAR-T Begins the Jump from Blood Cancers to B-Cell Driven Autoimmune Disease
December 20th 2023Throughout 2023, interest in the application of CAR-T and other cell therapies to B-cell-driven autoimmune disease skyrocketed, with a multitude of clinical trials being initiated by various companies.
Abeona Receives Breakthrough Designation for Rare Skin Disease Gene Therapy
August 31st 2017A gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), a rare skin disease that causes the skin to be very fragile and blister easily, has been granted Breakthrough Therapy designation status by the FDA.